Paul R Sheehe. Show Affiliations »
Abstract
Mesh： See more » Endpoint DeterminationHumansHypoglycemic Agents/therapeutic useKaplan-Meier EstimateProportional Hazards ModelsRandomized Controlled Trials as TopicRosiglitazoneThiazolidinediones/therapeutic use
Substances： See more » Hypoglycemic AgentsThiazolidinedionesRosiglitazone
Year: 2010 PMID： 20442384 DOI： 10.1001/jama.2010.522
Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272